Literature DB >> 7811531

Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix.

J Kaminchik1, R Margalit, S Yaish, H Drummer, B Amit, N Sarver, M Gorecki, A Panet.   

Abstract

Cellular distribution of HIV-1 Nef protein was studied by expressing the protein in mammalian cells. Cell extracts were fractionated by low- and high-speed centrifugation and by nonionic detergents. Two Nef-related proteins were expressed in COS cells, Nef-27kD and Nef-25kD. Nef-27kD, an N-myristoylated form of Nef, was found in the cytosol and in association with a particulate fraction of the cytoplasm. Treatment of the particulate cytoplasmic fraction with nonionic detergents, using three different protocols designed to isolate the cytoskeleton matrix, indicated that part of Nef was sensitive and part was resistant to detergent solubilization. These two cellular fractions represent membrane- and cytoskeleton-associated Nef. Nef-25kD, initiated from an in-frame AUG codon, was not modified with myristic acid at the amino terminus. Consequently, this protein was present in a soluble form in the cytosol. Furthermore, a mutant of Nef-27kD, in which the myristoylation signal is deleted, appears as a cytoplasmic soluble protein. To determine domains in Nef that are responsible for its subcellular distribution, successive internal deletions of 14-20 amino acids were introduced at the N-terminal portion of the protein. Five mutants were evaluated with respect to their cellular localization. One mutant (pSVLA-5), from which amino acids 73-88 were deleted, did not copurify with the detergent-insoluble fraction. The protein was, however, present in the particulate cytoplasmic fraction, presumably in association with membranes. Taken together, these results suggest that N-myristoylation of Nef affects its association with both membranes and cytoskeleton.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811531     DOI: 10.1089/aid.1994.10.1003

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  21 in total

1.  Effects of HIV-1 Nef on human N-myristoyltransferase 1.

Authors:  Christopher R Morgan; Brian V Miglionico; John R Engen
Journal:  Biochemistry       Date:  2011-03-30       Impact factor: 3.162

2.  The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.

Authors:  S Swingler; P Gallay; D Camaur; J Song; A Abo; D Trono
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

3.  Heterologous Src homology 4 domains support membrane anchoring and biological activity of HIV-1 Nef.

Authors:  Miriam M Geist; Xiaoyu Pan; Silke Bender; Ralf Bartenschlager; Walter Nickel; Oliver T Fackler
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

4.  Altered plaque formation by recombinant vaccinia virus expressing simian immunodeficiency virus Nef.

Authors:  M K Yamanaka; T Yilma
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.

Authors:  C Aiken; D Trono
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Self-association of the Lentivirus protein, Nef.

Authors:  Youn Tae Kwak; Alexa Raney; Lillian S Kuo; Sarah J Denial; Brenda R S Temple; J Victor Garcia; John L Foster
Journal:  Retrovirology       Date:  2010-09-23       Impact factor: 4.602

7.  Function of ubiquitin (Ub) specific protease 15 (USP15) in HIV-1 replication and viral protein degradation.

Authors:  Dohun Pyeon; Khalid Amine Timani; Fahad Gulraiz; Johnny J He; In-Woo Park
Journal:  Virus Res       Date:  2016-07-25       Impact factor: 3.303

8.  HIV-1 Nef perturbs artificial membranes: investigation of the contribution of the myristoyl anchor.

Authors:  Ruth Szilluweit; Annegret Boll; Sonja Lukowski; Holger Gerlach; Oliver T Fackler; Matthias Geyer; Claudia Steinem
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

9.  Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics.

Authors:  T Luo; S J Anderson; J V Garcia
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 10.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.